Graft microvascular disease in solid organ transplantation

Journal of Molecular Medicine

Volumn 92, Issue 8, 2014, Pages 797-810

  Jiang, Xinguo ^a,b   Sung, Yon K ^a,b   Tian, Wen ^a,b   Qian, Jin ^a,b   Semenza, Gregg L ^c   Nicolls, Mark R ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic rejection; Endothelial cells; Fibrosis; Graft microvascular disease; Transplantation

Indexed keywords

ALLOANTIBODY; CYCLOSPORIN A; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROCOAGULANT; RANTES; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE GRAFT REJECTION; ANGIOGENESIS; APOPTOSIS; CELL DAMAGE; CELL DEATH; CELL EXPANSION; CELL MIGRATION; CYTOKINE PRODUCTION; EMBRYO DEVELOPMENT; ENDOTHELIAL PROGENITOR CELL; GRAFT DYSFUNCTION; GRAFT MICROVASCULAR DISEASE; GRAFT SURVIVAL; HUMAN; IMMUNOCOMPETENT CELL; LONG TERM SURVIVAL; MACROPHAGE; MICROANGIOPATHY; NEUTROPHIL; NONHUMAN; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; REVIEW; THROMBOSIS; VASCULAR SMOOTH MUSCLE; VASCULAR SURGERY; ADVERSE EFFECTS; ANIMAL; ENDOTHELIUM CELL; FIBROSIS; GRAFT REJECTION; IMMUNOLOGY; METABOLISM; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULAR DISEASES; VASCULAR REMODELING;

ANIMALS; ENDOTHELIAL CELLS; FIBROSIS; GRAFT REJECTION; HUMANS; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN TRANSPLANTATION; THROMBOSIS; VASCULAR DISEASES; VASCULAR REMODELING;

EID: 84906791242     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-014-1173-y     Document Type: Review

References (182)

1. Serne EH, de Jongh RT, Eringa EC, Ijzerman RG, Stehouwer CD (2007) Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome. Hypertension 50:204-211 (Pubitemid 46986042)
2. Martinez-Lemus LA (2012) The dynamic structure of arterioles. Basic Clin Pharm Toxicol 110:5-11
3. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97:512-523 (Pubitemid 41361741)
4. Muris DM, Houben AJ, Schram MT, Stehouwer CD (2013) Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance. Rev Endocr Metab Disord 14:29-38
5. Muris DM, Houben AJ, Schram MT, Stehouwer CD (2012) Microvascular dysfunction is associated with a higher incidence of type 2 diabetes mellitus: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 32:3082-3094
6. Campanholle G, Ligresti G, Gharib SA, Duffield JS (2013) Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol 304:C591-C603
7. Rabquer BJ, Koch AE (2012) Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts. Curr Rheumatol Rep 14:56-63
8. Herrmann J, Kaski JC, Lerman A (2012) Coronary microvascular dysfunction in the clinical setting: frommystery to reality. Eur Heart J 33:2771-2782b
9. Mitchell RN (2009) Graft vascular disease: immune response meets the vessel wall. Annu Rev Pathol 4:19-47
10. Babu AN, Murakawa T, Thurman JM, Miller EJ, Henson PM, Zamora MR, Voelkel NF, Nicolls MR (2007) Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis. J Clin Invest 117:3774-3785 (Pubitemid 350224088)
11. Jiang X, Khan MA, Tian W, Beilke J, Natarajan R, Kosek J, Yoder MC, Semenza GL, Nicolls MR (2011) Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest 121:2336-2349
12. Tuuminen R, Syrjala S, Krebs R, Keranen MA, Koli K, Abo-Ramadan U, Neuvonen PJ, Tikkanen JM, Nykanen AI, Lemstrom KB (2011) Donor simvastatin treatment abolishes rat cardiac allograft ischemia/reperfusion injury and chronic rejection through microvascular protection. Circulation 124:1138-1150
13. Bishop GA, Waugh JA, Landers DV, Krensky AM, Hall BM (1989) Microvascular destruction in renal transplant rejection. Transplantation 48:408-414 (Pubitemid 19236503)
14. Matsumoto Y, McCaughan GW, Painter DM, Bishop GA (1993) Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation 56:69-75 (Pubitemid 23220574)
15. Luckraz H, Goddard M, McNeil K, Atkinson C, Charman SC, Stewart S, Wallwork J (2004) Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation. J Heart and Lung Transplant : Off Publ Int Soc Heart Transplant 23:527-531 (Pubitemid 38595735)
16. Luckraz H, Goddard M, McNeil K, Atkinson C, Sharples LD, Wallwork J (2006) Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways? Ann Thorac Surg 82:1212-1218 (Pubitemid 44402309)
17. Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos S, Gilbert EM, Everitt M, Budge D, Alharethi R, Snow G et al (2012) Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. Cardiovasc Pathol : Off J Soc Cardiovasc Pathol 21:445-454
18. Chung AS, Ferrara N (2011) Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27:563-584
19. Shimizu K, Mitchell RN (2008) The role of chemokines in transplant graft arterial disease. Arterioscler Thromb Vasc Biol 28:1937-1949
20. Mitchell RN (2013) Learning from rejection: what transplantation teaches us about (other) vascular pathologies. J Autoimmun 45:80-89
21. Semenza GL (2007) Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem 102:840-847
22. Marcelo KL, Goldie LC, Hirschi KK (2013) Regulation of endothelial cell differentiation and specification. Circ Res 112:1272-1287
23. Yamaguchi TP, Harpal K, Henkemeyer M, Rossant J (1994) fgfr-1 is required for embryonic growth andmesodermal patterning during mouse gastrulation. Genes Dev 8:3032-3044
24. Winnier G, Blessing M, Labosky PA, Hogan BL (1995) Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9:2105-2116
25. Chang H, Huylebroeck D, Verschueren K, Guo Q, Matzuk MM, Zwijsen A (1999) Smad5 knockoutmice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 126: 1631-1642 (Pubitemid 29204328)
26. Pearson S, Sroczynska P, Lacaud G, Kouskoff V (2008) The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF. Development 135:1525-1535 (Pubitemid 351753642)
27. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967 (Pubitemid 27087709)
28. Richardson MR, Yoder MC (2011) Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 50:266-272
29. Basile DP, Yoder MC (2014) Circulating and tissue resident endothelial progenitor cells. J Cell Physiol 229:10-16
30. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395
31. Mac Gabhann F, Peirce SM (2010) Collateral capillary arterialization following arteriolar ligation in murine skeletal muscle. Microcirculation 17:333-347
32. Takeda Y, Costa S, Delamarre E, Roncal C, Leite de Oliveira R, Squadrito ML, Finisguerra V, Deschoemaeker S, Bruyere F, Wenes M et al (2011) Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479:122-126
33. Moraes F, Paye J, Mac Gabhann F, Zhuang ZW, Zhang J, Lanahan AA, Simons M (2013) Endothelial cell-dependent regulation of arteriogenesis. Circ Res 113:1076-1086
34. Potente M, Gerhardt H, Carmeliet P (2011) Basic and therapeutic aspects of angiogenesis. Cell 146:873-887
35. Phng LK, Gerhardt H (2009) Angiogenesis: a team effort coordinated by notch. Dev Cell 16:196-208
36. Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298-307
37. De Bock K, Georgiadou M, Schoors S, Kuchnio A, Wong BW, Cantelmo AR, Quaegebeur A, Ghesquiere B, Cauwenberghs S, Eelen G et al (2013) Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154:651-663
38. Corada M, Nyqvist D, Orsenigo F, Caprini A, Giampietro C, Taketo MM, Iruela-Arispe ML, Adams RH, Dejana E (2010) The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev Cell 18:938-949
39. De Bock K, Georgiadou M, Carmeliet P (2013) Role of endothelial cell metabolism in vessel sprouting. Cell Metab 18:634-647
40. Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G (2006) Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444:1032-1037 (Pubitemid 46018516)
41. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I et al (2006) Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444:1083-1087 (Pubitemid 46018529)
42. Al-Lamki RS, Bradley JR, Pober JS (2008) Endothelial cells in allograft rejection. Transplantation 86:1340-1348
43. Pober JS, Min W, Bradley JR (2009) Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 4:71-95
44. Sis B (2012) Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection. Hum Immunol 73:1218-1225
45. Mehra NK, Siddiqui J, Baranwal A, Goswami S, Kaur G (2013) Clinical relevance of antibody development in renal transplantation. Ann N YAcad Sci 1283:30-42
46. Choy JC (2010) Granzymes and perforin in solid organ transplant rejection. Cell Death Differ 17:567-576
47. Russell JH, Ley TJ (2002) Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20:323-370 (Pubitemid 34293428)
48. Barry M, Bleackley RC (2002) Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2:401-409 (Pubitemid 37328747)
49. Choy JC, Kerjner A, Wong BW, McManus BM, Granville DJ (2004) Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts. Am J Pathol 165:127-133 (Pubitemid 38821820)
50. Chowdhury D, Lieberman J (2008) Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 26:389-420 (Pubitemid 351611623)
51. Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, Freudenberg M, Kim S, Raja SM, Shi L, Simon MM et al (2008) Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29:720-733
52. Zheng L, Ben LH, Pober JS, Bothwell AL (2002) Porcine endothelial cells, unlike human endothelial cells, can be killed by human CTL via Fas ligand and cannot be protected by Bcl-2. J Immunol 169:6850-6855 (Pubitemid 36899270)
53. Imanishi T, McBride J, Ho Q, O'Brien KD, Schwartz SM, Han DK (2000) Expression of cellular FLICE-inhibitory protein in human coronary arteries and in a rat vascular injury model. Am J Pathol 156:125-137 (Pubitemid 30644445)
54. Li JH, Kluger MS, Madge LA, Zheng L, Bothwell AL, Pober JS (2002) Interferon-gamma augments CD95(APO-1/Fas) and procaspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Am J Pathol 161:1485-1495
55. Lieberman J (2003) The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 3:361-370
56. Mannon RB (2012) Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders? Curr Opinion Organ Transplant 17:20-25
57. Jiang X, Tian W, Sung YK, Qian J, Nicolls MR (2014) Macrophage in solid organ transplantation. Vascular Cell 6:5
58. Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, Kurup S, Glass DA, Patel MS, Shu W et al (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437:417-421 (Pubitemid 41613504)
59. Hubert KE, Davies MH, Stempel AJ, Griffith TS, Powers MR (2009) TRAIL-deficient mice exhibit delayed regression of retinal neovascularization. Am J Pathol 175:2697-2708
60. Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P (2004) Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 24:1309-1314 (Pubitemid 38880026)
61. Adair A, Mitchell DR, Kipari T, Qi F, Bellamy CO, Robertson F, Hughes J, Marson LP (2007) Peritubular capillary rarefaction and lymphangiogenesis in chronic allograft failure. Transplantation 83:1542-1550 (Pubitemid 46987904)
62. Tian W, Jiang X, Tamosiuniene R, Sung YK, Qian J, Dhillon G, Gera L, Farkas L, Rabinovitch M, Zamanian RT et al (2013) Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension. Sci Transl Med 5:200ra117
63. Jiang X (2014) Harnessing the immune system for the treatment of breast cancer. J Zhejiang Univ Sci B 15:1-15
64. Gorbacheva V, Fan R, Li X, Valujskikh A (2010) Interleukin-17 promotes early allograft inflammation. Am J Pathol 177:1265-1273
65. Celli S, Albert ML, Bousso P (2011) Visualizing the innate and adaptive immune responses underlying allograft rejection by twophoton microscopy. Nat Med 17:744-749
66. Miura M, El-Sawy T, Fairchild RL (2003) Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am J Pathol 162:509-519 (Pubitemid 36267858)
67. Surquin M, Le Moine A, Flamand V, Rombaut K, Demoor FX, Salmon I, Goldman M, Abramowicz D (2005) IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts. Transplantation 80:1485-1492 (Pubitemid 41803632)
68. El-Sawy T, Belperio JA, Strieter RM, Remick DG, Fairchild RL (2005) Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation 112:320-331 (Pubitemid 41022072)
69. Diamantopoulos AP (2013) Extracellular neutrophil traps: a novel therapeutic target in ANCA-associated vasculitis? Front Immunol 4:24
70. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD et al (2007) Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13:463-469 (Pubitemid 46559832)
71. Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, Grone HJ, Brinkmann V, Jenne DE (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15:623-625
72. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT (2009) Extracellular histones are major mediators of death in sepsis. Nat Med 15:1318-1321
73. Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, Lohmeyer J, Preissner KT (2012) Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE 7:e32366
74. Chong AS, Alegre ML, Miller ML, Fairchild RL (2013) Lessons and limits of mouse models. Cold Spring Harb Perspect Med. 3
75. Campbell P (2013) Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation. Curr Opin Organ Transplant 18:463-469
76. Lobo LJ, Aris RM, Schmitz J, Neuringer IP (2013) Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation. J Heart and Lung Transplant : Off Publ Int Soc Heart Transplant 32:70-77
77. Kittleson MM, Kobashigawa JA (2012) Antibody-mediated rejection. Curr Opin Organ Transplant 17:551-557
78. Smith RN, Colvin RB (2012) Chronic alloantibody mediated rejection. Semin Immunol 24:115-121
79. Stegall MD, Chedid MF, Cornell LD (2012) The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol 8:670-678
80. Cai J, Terasaki PI, Mao Q, Pham T, El-Awar N, Lee JH, Rebellato L (2006) Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens. Am J Transplant: Off J Am Soc Transplant Am Soc Transplant Surg 6:2947-2954
81. Krishnan NS, Zehnder D, Daga S, Lowe D, Lam FT, Kashi H, Tan LC, Imray C, Hamer R, Briggs D et al (2013) Behaviour of nondonor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantation. PLoS ONE 8:e68663
82. Moreau A, Varey E, Anegon I, Cuturi MC (2013) Effector mechanisms of rejection. Cold Spring Harb Perspect Med 3
83. Dragun D, Catar R, Philippe A (2013) Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance. Curr Opin Organ Transplant 18:430-435
84. Drachenberg CB, Papadimitriou JC (2013) Endothelial injury in renal antibody-mediated allograft rejection: a schematic view based on pathogenesis. Transplantation 95:1073-1083
85. Lawson C, Holder AL, Stanford RE, Smith J, Rose ML (2005) Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: a role in endothelial cell activation. Transplantation 80:264-271 (Pubitemid 41061685)
86. Iwata T, Philipovskiy A, Fisher AJ, Presson RG Jr, Chiyo M, Lee J, Mickler E, Smith GN, Petrache I, Brand DB et al (2008) Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 181:5738-5747
87. Jackson AM, Lucas DP, Melancon JK, Desai NM (2011) Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. Transplantation 92:54-60
88. Reinsmoen NL (2013) Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation. Hum Immunol 74:1474-1477
89. Rose ML (2013) Role of anti-vimentin antibodies in allograft rejection. Hum Immunol 74:1459-1462
90. Wood KJ, Goto R (2012) Mechanisms of rejection: current perspectives. Transplantation 93:1-10
91. Cole DS, Morgan BP (2003) Beyond lysis: how complement influences cell fate. Clin Sci (Lond) 104:455-466 (Pubitemid 36628141)
92. Forbes RD, Guttmann RD (1982) Evidence for complementinduced endothelial injury in vivo: a comparative ultrastructural tracer study in a controlled model of hyperacute rat cardiac allograft rejection. Am J Pathol 106:378-387 (Pubitemid 12192660)
93. Hughes J, Nangaku M, Alpers CE, Shankland SJ, Couser WG, Johnson RJ (2000) C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am J Physiol Renal Physiol 278:F747-F757 (Pubitemid 30351076)
94. Nauta AJ, Daha MR, Tijsma O, van de Water B, Tedesco F, Roos A (2002) The membrane attack complex of complement induces caspase activation and apoptosis. Eur J Immunol 32:783-792 (Pubitemid 34257556)
95. Nakashima S, Qian Z, Rahimi S, Wasowska BA, Baldwin WM 3rd (2002) Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection. J Immunol 169:4620-4627 (Pubitemid 35178242)
96. Khan MA, Jiang X, Dhillon G, Beilke J, Holers VM, Atkinson C, Tomlinson S, Nicolls MR (2011) CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants. Circ Res 109:1290-1301
97. Khan MA, Maasch C, Vater A, Klussmann S, Morser J, Leung LL, Atkinson C, Tomlinson S, Heeger PS, Nicolls MR (2013) Targeting complement component 5a promotes vascular integrity and limits airway remodeling. Proc Natl Acad Sci U S A 110:6061-6066
98. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM et al (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12:682-687 (Pubitemid 43865238)
99. Flierl MA, Rittirsch D, Chen AJ, Nadeau BA, Day DE, Sarma JV, Huber-Lang MS, Ward PA (2008) The complement anaphylatoxin C5a induces apoptosis in adrenomedullary cells during experimental sepsis. PLoS ONE 3:e2560
100. Albrecht EA, Sarma JV, Ward PA (2009) Activation by C5a of endothelial cell caspase 8 and cFLIP. Inflamm Res 58:30-37
101. Colvin RB, Smith RN (2005) Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5:807-817 (Pubitemid 41400854)
102. Valenzuela NM, McNamara JT, Reed EF (2013) Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. Current Opin Organ Transplant 19:33-40
103. Tedesco F, Pausa M, Nardon E, Introna M, Mantovani A, Dobrina A (1997) The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 185:1619-1627 (Pubitemid 27203258)
104. Kilgore KS, Schmid E, Shanley TP, Flory CM, Maheswari V, Tramontini NL, Cohen H, Ward PA, Friedl HP, Warren JS (1997) Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol 150:2019-2031 (Pubitemid 27233075)
105. Brunn GJ, Saadi S, Platt JL (2006) Differential regulation of endothelial cell activation by complement and interleukin 1α. Circ Res 98:793-800
106. Selvan RS, Kapadia HB, Platt JL (1998) Complement-induced expression of chemokine genes in endothelium: regulation by IL-1-dependent and -independent mechanisms. J Immunol 161:4388-4395 (Pubitemid 28469025)
107. Jane-Wit D, Manes TD, Yi T, Qin L, Clark P, Kirkiles-Smith NC, Abrahimi P, Devalliere J, Moeckel G, Kulkarni S et al (2013) Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-kappaB signaling in endothelial cells. Circulation 128:2504-2516
108. Viedt C, Hansch GM, Brandes RP, Kubler W, Kreuzer J (2000) The terminal complement complex C5b-9 stimulates interleukin-6 production in human smooth muscle cells through activation of transcription factors NF-kappa B and AP-1. FASEB J: Off Publ Fed Am Soc Exp Biol 14:2370-2372
109. Yamakuchi M, Kirkiles-Smith NC, Ferlito M, Cameron SJ, Bao C, Fox-Talbot K, Wasowska BA, Baldwin WM 3rd, Pober JS, Lowenstein CJ (2007) Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci U S A 104:1301-1306 (Pubitemid 46183999)
110. Valenzuela NM, Hong L, Shen XD, Gao F, Young SH, Rozengurt E, Kupiec-Weglinski JW, Fishbein MC, Reed EF (2013) Blockade of P-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo. Am J Transplant: Off J Am Soc Transplant Am Soc Transplant Surg 13:299-311
111. Valenzuela NM, Mulder A, Reed EF (2013) HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcgammaRs. J Immunol 190:6635-6650
112. Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25:29-38 (Pubitemid 40054251)
113. Fonseca I, Reguengo H, Almeida M, Dias L, Martins LS, Pedroso S, Santos J, Lobato L, Henriques AC, Mendonca D (2014) Oxidative stress in kidney transplantation: malondialdehyde is an early predictive marker of graft dysfunction. Transplantation
114. Czubkowski P, Socha P, Pawlowska J (2011) Oxidative stress in liver transplant recipients. Ann Transplant: Q Polish Transplant Soc 16:99-108
115. Reid D, Snell G, Ward C, Krishnaswamy R, Ward R, Zheng L, Williams T, Walters H (2001) Iron overload and nitric oxide-derived oxidative stress following lung transplantation. J Heart Lung Transplant: Off Publ Int Soc Heart Transplant 20:840-849 (Pubitemid 32737520)
116. Witman MA, Fjeldstad AS, McDaniel J, Ives SJ, Zhao J, Barrett-O'Keefe Z, Nativi JN, Stehlik J, Wray DW, Richardson RS (2012) Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond. Hypertension 60:659-668
117. Madill J, Aghdassi E, Arendt B, Hartman-Craven B, Gutierrez C, Chow CW, Allard J, University Health N (2009) Lung transplantation: does oxidative stress contribute to the development of bronchiolitis obliterans syndrome? Transplant Rev 23:103-110
118. Land WG (2012) Emerging role of innate immunity in organ transplantation: part I: evolution of innate immunity and oxidative allograft injury. Transplant Rev 26:60-72
119. Wolf A, Trendelenburg CF, Diez-Fernandez C, Prieto P, Houy S, Trommer WE, Cordier A (1997) Cyclosporine A-induced oxidative stress in rat hepatocytes. J Pharm Exp Ther 280:1328-1334 (Pubitemid 27166730)
120. O'Connell S, Tuite N, Slattery C, Ryan MP, McMorrow T (2012) Cyclosporine A - induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci : Off J Soc Toxicol 126:101-113
121. Jabs A, Gobel S, Wenzel P, Kleschyov AL, Hortmann M, Oelze M, Daiber A, Munzel T (2008) Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation. J Am College Cardiol 51:2130-2138 (Pubitemid 351713680)
122. Bradley JR, Johnson DR, Pober JS (1993) Endothelial activation by hydrogen peroxide. Selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. Am J Pathol 142:1598-1609 (Pubitemid 24058146)
123. Gargalovic PS, Imura M, Zhang B, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Patel S et al (2006) Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci U S A 103:12741-12746 (Pubitemid 44298631)
124. Jiang X, Malkovskiy AV, Tian W, Sung YK, Sun W, Hsu JL, Manickam S, Wagh D, Joubert LM, Semenza GL et al (2014) Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles. Biomaterials 35:803-813
125. Sinha K, Das J, Pal PB, Sil PC (2013) Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 87:1157-1180
126. Song JJ, Lee YJ (2003) Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem J 373:845-853 (Pubitemid 36981094)
127. Liu Y, Min W (2002) Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 90:1259-1266 (Pubitemid 34787407)
128. Zhang L, Chen J, Fu H (1999) Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci U S A 96:8511-8515 (Pubitemid 29354822)
129. Zhang W, Zheng S, Storz P, Min W (2005) Protein kinase D specifically mediates apoptosis signal-regulating kinase 1-JNK signaling induced by H2O2 but not tumor necrosis factor. J Biol Chem 280:19036-19044 (Pubitemid 41379609)
130. Zhang R, Al-Lamki R, Bai L, Streb JW, Miano JM, Bradley J, Min W (2004) Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res 94:1483-1491 (Pubitemid 38780321)
131. Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K, Yamazaki K, Nakabayashi M, Ogihara T, Kaneda Y (2001) Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 38:48-55 (Pubitemid 34224770)
132. Tepperman E, Ramzy D, Prodger J, Sheshgiri R, Badiwala M, Ross H, Raoa V (2010) Surgical biology for the clinician: vascular effects of immunosuppression. Can J Surg J canadien de chirurgie 53:57-63
133. Trapp A, Weis M (2005) The impact of immunosuppression on endothelial function. J Cardiovasc Pharmacol 45:81-87 (Pubitemid 40039760)
134. Fyfe AI, Rosenthal A, Gotlieb AI (1995) Immunosuppressive agents and endothelial repair. Prednisolone delays migration and cytoskeletal rearrangement in wounded porcine aortic monolayers. Arterioscler Thromb Vasc Biol 15:1166-1171
135. Morris ST, McMurray JJ, Rodger RS, Farmer R, Jardine AG (2000) Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 57:1100-1106 (Pubitemid 30434799)
136. Kidokoro K, Satoh M, Nagasu H, Sakuta T, Kuwabara A, Yorimitsu D, Nishi Y, Tomita N, Sasaki T, Kashihara N (2012) Tacrolimus induces glomerular injury via endothelial dysfunction caused by reactive oxygen species and inflammatory change. Kidney & Blood Press Res 35:549-557
137. Petrakopoulou P, Anthopoulou L, Muscholl M, Klauss V, von Scheidt W, Uberfuhr P, Meiser BM, Reichart B, Weis M (2006) Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression. J Am Coll Cardiol 47:1622-1629
138. Gross PL, Aird WC (2000) The endotheliumand thrombosis. Semin Thromb Hemost 26:463-478
139. Puschel A, Lindenblatt N, Katzfuss J, Vollmar B, Klar E (2012) Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation. Surgery 151:26-36
140. Labarrere CA, Nelson DR, Faulk WP (1998) Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients. Am J Med 105:207-213 (Pubitemid 28443209)
141. Labarrere CA, Deng MC (2002) Microvascular prothrombogenicity and transplant coronary artery disease. Transpl Immunol 9:243-249
142. Labarrere CA, Ortiz MA, Ruzmetov N, Sosa MJ, Campana G, Terry C, Baldridge LA, Antonopoulos R, DiCarlo HL (2006) Microvascular thrombosis and cardiac allograft vasculopathy in rat heart transplantation. J Heart and Lung Transplant: Off Publ Int Soc Heart Transplant 25:1213-1222 (Pubitemid 44528287)
143. Aramaki O, Takayama T, Yokoyama T, Takano S, Akiyama Y, Shibutani S, Shirasugi N, Kan S, Ikeda Y, Niimi M (2002) Intravenous administration of antithrombin III induces indefinite survival of fully allogeneic cardiac grafts. Transplant Proc 34:1409-1410
144. Preidl RH, Eckl S, Ramsperger-Gleixner M, Koch N, Spriewald BM, Weyand M, Ensminger SM (2013) Clopidogrel reduces post-transplant obliterative bronchiolitis. Transplant int: Official J Eur Soc Organ Transplant 26:1038-1048
145. Jiang X, Orr BA, Kranz DM, Shapiro DJ (2006) Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells. Endocrinology 147:1419-1426 (Pubitemid 43244376)
146. Jiang X, Ellison SJ, Alarid ET, Shapiro DJ (2007) Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 26:4106-4114 (Pubitemid 46920175)
147. Matsunami K, Kondo A, Nakatsu S, Omori T, Nakagawa T, Otsuka H, Fukuzawa M, Miyagawa S (2007) Cloning of pig serine proteinase inhibitor 9 and its use in protecting against apoptosis. Transplant int: Off J Euro Soc Organ Transplant 20:453-459
148. Buzza MS, Hirst CE, Bird CH, Hosking P, McKendrick J, Bird PI (2001) The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell Immunol 210:21-29 (Pubitemid 32756938)
149. Bach FH, Ferran C, Hechenleitner P, Mark W, Koyamada N, Miyatake T, Winkler H, Badrichani A, Candinas D, Hancock WW (1997) Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3:196-204 (Pubitemid 27064705)
150. Tabata T, de Perrot M, Keshavjee S, Liu M, Downey GP, Waddell TK (2003) Accommodation after lung xenografting from hamster to rat. Transplantation 75:607-612 (Pubitemid 36337356)
151. Fukami N, Ramachandran S, Narayanan K, Liu W, Nath DS, Jendrisak M, Chapman W, Mohanakumar T (2012) Mechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant model. Transplantation 93:364-372
152. Salama AD, Delikouras A, Pusey CD, Cook HT, Bhangal G, Lechler RI, Dorling A (2001) Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. Am J Transplant: Off J Am Soc Transplant Am Soc Transplant Surg 1:260-269 (Pubitemid 33674170)
153. Narayanan K, Jendrisak MD, Phelan DL, Mohanakumar T (2006) HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Transpl Immunol 15:187-197 (Pubitemid 43129385)
154. Gonzalez-Stawinski GV, Tan CD, Smedira NG, Starling RC, Rodriguez ER (2008) Decay-accelerating factor expression may provide immunoprotection against
155. Tan CD, Sokos GG, Pidwell DJ, Smedira NG, Gonzalez-Stawinski GV, Taylor DO, Starling RC, Rodriguez ER (2009) Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection. Am J Transplant 9:2075-2084
156. Suzuki H, Lasbury ME, Fan L, Vittal R, Mickler EA, Benson HL, Shilling R, Wu Q, Weber DJ, Wagner SR et al (2013) Role of complement activation in obliterative bronchiolitis post-lung transplantation. J Immunol 191:4431-4439
157. Bauer A, Renz V, Baschnegger H, Abicht JM, Beiras-Fernandez A, Brenner P, Thein E, Schmoeckel M, Reichart B, Christ F (2011) Microcirculatory alterations after orthotopic pig-to-baboon heart transplantation. Xenotransplantation 18:232-238
158. Mason JC, Lidington EA, Ahmad SR, Haskard DO (2002) bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction. Am J Physiol Cell Physiol 282:C578-C587 (Pubitemid 34663174)
159. Mason JC, Steinberg R, Lidington EA, Kinderlerer AR, Ohba M, Haskard DO (2004) Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-α/ε (PKCα/ε)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A. J Biol Chem 279:41611-41618 (Pubitemid 39313604)
160. Mason JC, Yarwood H, Sugars K, Morgan BP, Davies KA, Haskard DO (1999) Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition. Blood 94:1673-1682 (Pubitemid 29411317)
161. Kinderlerer AR, Ali F, Johns M, Lidington EA, Leung V, Boyle JJ, Hamdulay SS, Evans PC, Haskard DO, Mason JC (2008) KLF2-dependent, shear stress-induced expression of CD59: a novel cytoprotective mechanism agains t complement-mediated injury in the vasculature. J Biol Chem 283:14636-14644
162. Reinders ME, Rabelink TJ, Briscoe DM (2006) Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrol: JASN 17:932-942
163. Jiang X, Hsu JL, Tian W, Yuan K, Olcholski M, Perez Vde J, Semenza GL, Nicolls MR (2013) Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus. J Mol Med 91:1081-1093
164. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130:691-703 (Pubitemid 47268059)
165. Stockmann C, Doedens A, Weidemann A, Zhang N, Takeda N, Greenberg JI, Cheresh DA, Johnson RS (2008) Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 456:814-818
166. Sidky YA, Auerbach R (1975) Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction. J Exp Med 141:1084-1100
167. Auerbach R, Sidky YA (1979) Nature of the stimulus leading to lymphocyte-induced angiogenesis. J Immunol 123:751-754 (Pubitemid 9211248)
168. Contreras AG, Briscoe DM (2007) Every allograft needs a silver lining. J Clin Invest 117:3645-3648 (Pubitemid 350224071)
169. Bruneau S, Woda CB, Daly KP, Boneschansker L, Jain NG, Kochupurakkal N, Contreras AG, Seto T, Briscoe DM (2012) Key features of the intragraft microenvironment that determine long-term survival following transplantation. Front Immunol 3:54
170. Fosbrink M, Niculescu F, Rus V, Shin ML, Rus H (2006) C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1. J Biol Chem 281:19009-19018 (Pubitemid 44035404)
171. Wick G, Grundtman C, Mayerl C, Wimpissinger TF, Feichtinger J, Zelger B, Sgonc R, Wolfram D (2013) The immunology of fibrosis. Annu Rev Immunol 31:107-135
172. Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18:1028-1040
173. Strieter RM, Gomperts BN, Keane MP (2007) The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 117:549-556 (Pubitemid 46348509)
174. Belperio JA, Keane MP, Burdick MD, Gomperts B, Xue YY, Hong K, Mestas J, Ardehali A, Mehrad B, Saggar R et al (2005) Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J Clin Invest 115:1150-1162 (Pubitemid 40629034)
175. Naldini A, Carraro F (2005) Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm and Allergy 4:3-8 (Pubitemid 40584847)
176. Pu KM, Sava P, Gonzalez AL (2013) Microvascular targets for antifibrotic therapeutics. Yale J Biol Med 86:537-554
177. Tzouvelekis A, Harokopos V, Paparountas T, Oikonomou N, Chatziioannou A, Vilaras G, Tsiambas E, Karameris A, Bouros D, Aidinis V (2007) Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1α in disease pathogenesis. Am J Respir Crit Care Med 176:1108-1119 (Pubitemid 350223757)
178. Watson CJ, Collier P, Tea I, Neary R, Watson JA, Robinson C, Phelan D, Ledwidge MT, McDonald KM, McCann A, Sharaf O, Baugh JA (2013) Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype. Human molecular genetics
179. Higgins DF, Kimura K, Iwano M, Haase VH (2008) Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 7:1128-1132 (Pubitemid 351749261)
180. Nath B, Szabo G (2012) Hypoxia and hypoxia inducible factors: diverse roles in liver diseases. Hepatology 55:622-633
181. Piera-Velazquez S, Li Z, Jimenez SA (2011) Role of endothelial- mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 179:1074-1080
182. Duffield JS, Lupher M, Thannickal VJ, Wynn TA (2013) Host responses in tissue repair and fibrosis. Annu Rev Pathol 8:241-276